| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director | Common Stock | 183,035 | $9,748,261 | $53.26 | 29 Nov 2024 | Direct |
| HALOZYME THERAPEUTICS, INC. | Director | Option to Purchase Common Stock | 8,804 | $122,111 | $13.87 | 25 Apr 2024 | Direct |
| SUTRO BIOPHARMA, INC. | Director | Common Stock | 50,000 | $39,950 | $0.7990 | 15 Oct 2025 | Direct |
| ARTELO BIOSCIENCES, INC. | Director | Warrant (right to buy) | 70,376 | 28 Oct 2025 | Direct | ||
| SUTRO BIOPHARMA, INC. | Director | Stock Option (right to buy) | 1,500 | 23 Dec 2025 | Direct | ||
| ARTELO BIOSCIENCES, INC. | Director | Stock Options (right to buy) | 292 | 30 Jan 2026 | Direct | ||
| ARTELO BIOSCIENCES, INC. | Director | Convertible Promissory Note | $110,843 | 28 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARTL | ARTELO BIOSCIENCES, INC. | 30 Jan 2026 | 1 | $0 | 4 | Director | 02 Feb 2026, 16:57 |
| STRO | SUTRO BIOPHARMA, INC. | 23 Dec 2025 | 1 | $0 | 4 | Director | 29 Dec 2025, 17:03 |
| ARTL | ARTELO BIOSCIENCES, INC. | 28 Oct 2025 | 4 | -$29,157 | 4 | Director | 30 Oct 2025, 21:30 |
| STRO | SUTRO BIOPHARMA, INC. | 15 Oct 2025 | 1 | +$39,950 | 4 | Director | 16 Oct 2025, 08:15 |
| STRO | SUTRO BIOPHARMA, INC. | 06 Jun 2025 | 1 | $0 | 4 | Director | 10 Jun 2025, 16:12 |
| ARTL | ARTELO BIOSCIENCES, INC. | 01 May 2025 | 1 | +$140,000 | 4 | Director | 05 May 2025, 17:21 |
| ARTL | ARTELO BIOSCIENCES, INC. | 20 Dec 2024 | 1 | $0 | 4 | Director | 23 Dec 2024, 16:02 |
| HALO | HALOZYME THERAPEUTICS, INC. | 29 Nov 2024 | 1 | $0 | 4 | Director | 03 Dec 2024, 16:05 |
| STRO | SUTRO BIOPHARMA, INC. | 06 Jun 2024 | 1 | $0 | 4 | Director | 10 Jun 2024, 16:26 |
| HALO | HALOZYME THERAPEUTICS, INC. | 25 Apr 2024 | 2 | $0 | 4 | Director | 29 Apr 2024, 18:05 |
| ARTL | ARTELO BIOSCIENCES, INC. | 28 Feb 2024 | 12 | $0 | 4 | Director | 01 Mar 2024, 18:09 |
| ARTL | ARTELO BIOSCIENCES, INC. | 04 Aug 2023 | 1 | $0 | 4 | Director | 08 Aug 2023, 16:58 |
| ARTL | ARTELO BIOSCIENCES, INC. | 30 Jun 2023 | 1 | $0 | 4 | Director | 03 Jul 2023, 14:05 |
| STRO | SUTRO BIOPHARMA, INC. | 08 Jun 2023 | 1 | $0 | 4 | Director | 12 Jun 2023, 18:38 |
| HALO | HALOZYME THERAPEUTICS, INC. | 05 May 2023 | 2 | $0 | 4 | Director | 09 May 2023, 18:21 |
| HALO | HALOZYME THERAPEUTICS, INC. | 16 Nov 2022 | 1 | $0 | 4 | Director | 17 Nov 2022, 16:11 |
| ARTL | ARTELO BIOSCIENCES, INC. | 24 Jun 2022 | 1 | $0 | 4 | Director | 27 Jun 2022, 17:20 |
| STRO | SUTRO BIOPHARMA, INC. | 06 Jun 2022 | 1 | $0 | 4 | Director | 08 Jun 2022, 19:07 |
| HALO | HALOZYME THERAPEUTICS, INC. | 05 May 2022 | 1 | $0 | 4 | Director | 06 May 2022, 20:06 |
| HALO | HALOZYME THERAPEUTICS, INC. | 05 Nov 2021 | 2 | -$1,292,113 | 4 | Director | 05 Nov 2021, 17:59 |
| ARTL | ARTELO BIOSCIENCES, INC. | 16 Jul 2021 | 1 | $0 | 4 | Director | 26 Jul 2021, 16:33 |
| STRO | SUTRO BIOPHARMA, INC. | 03 Jun 2021 | 1 | $0 | 4 | Director | 07 Jun 2021, 17:04 |